1me8: Difference between revisions
New page: left|200px<br /><applet load="1me8" size="450" color="white" frame="true" align="right" spinBox="true" caption="1me8, resolution 1.90Å" /> '''Inosine Monophosphat... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1me8.jpg|left|200px]]<br /><applet load="1me8" size=" | [[Image:1me8.jpg|left|200px]]<br /><applet load="1me8" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="1me8, resolution 1.90Å" /> | caption="1me8, resolution 1.90Å" /> | ||
'''Inosine Monophosphate Dehydrogenase (IMPDH) From Tritrichomonas Foetus with RVP bound'''<br /> | '''Inosine Monophosphate Dehydrogenase (IMPDH) From Tritrichomonas Foetus with RVP bound'''<br /> | ||
==Overview== | ==Overview== | ||
Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting | Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting step in GMP biosynthesis. The resulting intracellular pool of guanine nucleotides is of great importance to all cells for use in DNA and RNA synthesis, metabolism, and signal transduction. The enzyme binds IMP and the cofactor NAD(+) in random order, IMP is converted to XMP, NAD(+) is reduced to NADH, and finally, NADH and then XMP are released sequentially. XMP is subsequently converted into GMP by GMP synthetase. Drugs that decrease GMP synthesis by inhibiting IMPDH have been shown to have antiproliferative as well as antiviral activity. Several drugs are in use that target the substrate- or cofactor-binding site; however, due to differences between the mammalian and microbial isoforms, most drugs are far less effective against the microbial form of the enzyme than the mammalian form. The high resolution crystal structures of the protozoan parasite Tritrichomonas foetus IMPDH complexed with the inhibitor ribavirin monophosphate as well as monophosphate together with a second inhibitor, mycophenolic acid, are presented here. These structures reveal an active site cation identified previously only in the Chinese hamster IMPDH structure with covalently bound IMP. This cation was not found previously in apo IMPDH, IMPDH in complex with XMP, or covalently bound inhibitor, indicating that the cation-binding site may be catalysis-dependent. A comparison of T. foetus IMPDH with the Chinese hamster and Streptococcus pyogenes structures reveals differences in the active site loop architecture, which contributes to differences in cation binding during the catalytic sequence and the kinetic rates between bacterial, protozoan, and mammalian enzymes. Exploitation of these differences may lead to novel inhibitors, which favor the microbial form of the enzyme. | ||
==About this Structure== | ==About this Structure== | ||
1ME8 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Tritrichomonas_foetus Tritrichomonas foetus] with K, NA and RVP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/IMP_dehydrogenase IMP dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.205 1.1.1.205] Full crystallographic information is available from [http:// | 1ME8 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Tritrichomonas_foetus Tritrichomonas foetus] with <scene name='pdbligand=K:'>K</scene>, <scene name='pdbligand=NA:'>NA</scene> and <scene name='pdbligand=RVP:'>RVP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/IMP_dehydrogenase IMP dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.205 1.1.1.205] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ME8 OCA]. | ||
==Reference== | ==Reference== | ||
Line 15: | Line 15: | ||
[[Category: Tritrichomonas foetus]] | [[Category: Tritrichomonas foetus]] | ||
[[Category: Luecke, H.]] | [[Category: Luecke, H.]] | ||
[[Category: Prosise, G | [[Category: Prosise, G L.]] | ||
[[Category: Wu, J.]] | [[Category: Wu, J.]] | ||
[[Category: K]] | [[Category: K]] | ||
Line 22: | Line 22: | ||
[[Category: alpha beta barrel]] | [[Category: alpha beta barrel]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:54:26 2008'' |
Revision as of 14:54, 21 February 2008
|
Inosine Monophosphate Dehydrogenase (IMPDH) From Tritrichomonas Foetus with RVP bound
OverviewOverview
Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting step in GMP biosynthesis. The resulting intracellular pool of guanine nucleotides is of great importance to all cells for use in DNA and RNA synthesis, metabolism, and signal transduction. The enzyme binds IMP and the cofactor NAD(+) in random order, IMP is converted to XMP, NAD(+) is reduced to NADH, and finally, NADH and then XMP are released sequentially. XMP is subsequently converted into GMP by GMP synthetase. Drugs that decrease GMP synthesis by inhibiting IMPDH have been shown to have antiproliferative as well as antiviral activity. Several drugs are in use that target the substrate- or cofactor-binding site; however, due to differences between the mammalian and microbial isoforms, most drugs are far less effective against the microbial form of the enzyme than the mammalian form. The high resolution crystal structures of the protozoan parasite Tritrichomonas foetus IMPDH complexed with the inhibitor ribavirin monophosphate as well as monophosphate together with a second inhibitor, mycophenolic acid, are presented here. These structures reveal an active site cation identified previously only in the Chinese hamster IMPDH structure with covalently bound IMP. This cation was not found previously in apo IMPDH, IMPDH in complex with XMP, or covalently bound inhibitor, indicating that the cation-binding site may be catalysis-dependent. A comparison of T. foetus IMPDH with the Chinese hamster and Streptococcus pyogenes structures reveals differences in the active site loop architecture, which contributes to differences in cation binding during the catalytic sequence and the kinetic rates between bacterial, protozoan, and mammalian enzymes. Exploitation of these differences may lead to novel inhibitors, which favor the microbial form of the enzyme.
About this StructureAbout this Structure
1ME8 is a Single protein structure of sequence from Tritrichomonas foetus with , and as ligands. Active as IMP dehydrogenase, with EC number 1.1.1.205 Full crystallographic information is available from OCA.
ReferenceReference
Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site., Prosise GL, Wu JZ, Luecke H, J Biol Chem. 2002 Dec 27;277(52):50654-9. Epub 2002 Sep 13. PMID:12235158
Page seeded by OCA on Thu Feb 21 13:54:26 2008